1Hausson L, Ionchetti Am Carruthers S G, et al. Effects of intensive blood pressure lowering and low-dose aspirin in patient with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial[J]. Lancet, 1998,351(9118) :1755-1762.
2Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. The Sixth Report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure [J] . Arch Intern Med,1997,157(21) :2413.
3Gueyffer F, Bulpitt C, Boissel, J P, et al . Antihypertensive drugs in very old people: a subgroup metaanalysis of randomised controlled trials[J]. Lancet, 1999, 353 (9155):793-796.
4Staessen J A, Gasowski J, Wang J G, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: Meta analysis of outcome trials [J]. Lancet, 2000,355 (9207): 865-872.
5Sica D A. Current concepts of pharmacotherapy in hypertension-doxazosin-what does the future hold for it ?[J].Clin E Hypertens, 2000, 2(3): 222-224.
6Littlejohn T W. ABPM comparison of telmisartan and valsartan in patients with mild-to-moderate hypertension [J].Hypertens, 2000,18(suppl 2) : $97.
7Bjorn D, Richard B D. Cardivascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE) [J]. Lancet, 2002,359 (9311) :995-1003.
8Lasagna L. Diuretics vs alpha-blockers for treatment of hypertension:lessons from ALLHAT[J ]. JAMA, 2000, 283(5): 2013-2014.
9White W B. Benefits of antihypertensive therapy in older patients with hypertension [J]. Arch Intern Med, 2000, 160(2) : 149-150.
10Guidelines Subcommittee. 1999 World Health Organization.International Society of Hypertension Guidelines for the Management of Hypertension [J]. J Hypertens, 1999,17(2) :151.
